V
PRAX icon

Veritable’s Praxis Precision Medicines PRAX Stock Holding History

Veritable’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-794
Closed -$122K – 951
2022
Q1 		$122K Hold
794
– – ﹤0.01% 883
2021
Q4 		$235K Hold
794
– – ﹤0.01% 817
2021
Q3 		$220K Buy
+794
New +$215K ﹤0.01% 811

Other funds holding PRAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Veritable's PRAX Position: Q2 2022 in Review

Veritable sold out of Praxis Precision Medicines (PRAX) in Q2 2022, closing a stake of 794 shares — an estimated $122K sold.

Veritable first reported a position in PRAX in Q3 2021 and held it in 3 quarters. The position peaked at $235K in Q4 2021. 95 funds tracked by Wall St. Rank hold PRAX as of Q2 2022.

  • Veritable reported no remaining Praxis Precision Medicines position as of Q2 2022 after selling out during the quarter.
  • Veritable sold 794 Praxis Precision Medicines shares in Q2 2022, an estimated $122K.
  • Veritable first reported a position in Praxis Precision Medicines in Q3 2021 and held it in 3 quarters.
  • Veritable's Praxis Precision Medicines position peaked at $235K in Q4 2021.
  • 95 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2022.

Based on Veritable's 13F filing for Q2 2022, filed 15 Aug 2022.